Lipoprotein(a) immunoassays and their associations with coronary artery calcification and aortic valve calcification - 08/03/25
, Ching F. Khan, MD, MSc b, d, Fang Zhu, MPH, PhD c, Sunny S. Singh, MD, PhD e, f, Maryam Kavousi, MD, PhD, FESC c, Eric J.G. Sijbrands, MD PhD e, Yolanda B. de Rijke, PhD g, #, Daniel Bos, MD, PhD b, c, h, i, #ABSTRACT |
Background |
Lp(a) causes atherosclerosis and degenerative aortic valve disease, but concerns have risen that mass-based assays may beaffected by isoform sizes and provide inaccurate estimates of Lp(a) exposure.
Methods |
We compared contemporary immunoturbidimetric assays reporting either mass-based (Randox) or molar-based (Roche) using data from 5,129 unselected participants from the prospective population-based Rotterdam Study cohort. We studied the association of both Lp(a) measurements with the burden of coronary artery calcium (CAC) and aortic valve calcification (AVC) in a random subset of participants who underwent cardiac CT.
Results |
There was a near perfect linear correlation between Lp(a) concentrations from both immunoassays (R2 98.8%) with most pronounced differences apparent only at very high Lp(a) concentrations. Lp(a) concentrations were related with natural logtransformed Agatston scores (Randox standardized linear β 0.1003, P = 5.6·10−8; Roche standardized linear β 0.1004, P = 5.4·10−8). Lp(a) concentrations were strongly but similarly related to natural log-transformed AVC Agatston scores (Randox standardized linear β 0.1525, P = 9.2·10−16; Roche standardized linear β 0.1539, P = 4.8·10−16).
Conclusion |
We demonstrate that these immunoassays provide interchangeable Lp(a) measurements, and that associations with CAC and AVC were near-identical. This provides opportunities to directly compare findings from research done with either immunoassay.
Trial Registration |
The Rotterdam Study has been entered in the Netherlands National Trial Register and the WHO International Clinical Trials Registry Platform under shared catalog number NTR6831.
Il testo completo di questo articolo è disponibile in PDF.Mappa
Vol 284
P. 42-46 - Giugno 2025 Ritorno al numero
Articolo precedente
- Impact of a clinical atrial fibrillation risk estimation tool on cardiac rhythm monitor utilization following acute ischemic stroke: A prepost clinical trial
- Jeffrey M. Ashburner, Reinier W.P. Tack, Shaan Khurshid, Ashby C. Turner, Steven J. Atlas, Daniel E. Singer, Patrick T. Ellinor, Emelia J. Benjamin, Ludovic Trinquart, Steven A. Lubitz, Christopher D. Anderson
- Transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis aged 70 years or younger: A NOTION-2 substudy
- Troels Højsgaard Jørgensen, Hans Gustav Hørsted Thyregod, Mikko Savontaus, Öjvind Bleie, Evald H Christiansen, Matti Niemela, Oskar Angerås, Ingibjörg J. Gudmundsdóttir, Mika Laine, Andreas Rück, Bernard Prendergast, Martin Leon, Lars Søndergaard, Ole De Backer, NOTION-2 investigators
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?